GeneDx Holdings (WGS) Interest Expenses (2020 - 2026)

GeneDx Holdings (WGS) has reported Interest Expenses for 7 consecutive years, with $16.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses rose 15.59% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (up 15.59% YoY), while the FY2025 annual figure was $295.3 million, up 8.44% from the prior year.
• Interest Expenses climbed to $16.3 million in Q1 2026 per WGS's latest filing, from $2.9 million in the prior quarter.
• Across five years, Interest Expenses topped out at $19.5 million in Q3 2025 and bottomed at $137000.0 in Q4 2022.
• Historically, Interest Expenses has averaged $8.0 million across 5 years, with a median of $5.4 million in 2023.
• On a YoY basis, Interest Expenses climbed as much as 3829.93% in 2023 and fell as far as 98.79% in 2023.
• GeneDx Holdings' Interest Expenses stood at $137000.0 in 2022, then jumped by 3829.93% to $5.4 million in 2023, then plunged by 83.93% to $865000.0 in 2024, then soared by 231.21% to $2.9 million in 2025, then jumped by 468.94% to $16.3 million in 2026.
• Business Quant data shows WGS's Interest Expenses at $16.3 million in Q1 2026, $2.9 million in Q4 2025, and $19.5 million in Q3 2025.